The Aneurysm and AVM Foundation Grant Program (US and Canada)

TAAF Grants aim to support innovative research strategies that can lead to novel therapies, improved clinical management, and better recovery outcomes for both adult and pediatric patients. This opportunity is open to investigators at all stages of their careers, including those just starting their research journey.

Funding Information

• Grants will be awarded up to a maximum of $25,000, with funds restricted to direct costs only.

Eligibility Criteria

• Individuals involved in basic science, clinical care and epidemiological studies may submit applications. Currently, they are only accepting applications from investigators from the United States and Canada.
• Past TAAF grant recipients may apply. Scientific Advisory Council members may apply. In addition, TAAF may solicit applications. The Aneurysm and AVM Foundation requires full and timely disclosure regarding potential financial and/or intellectual overlap with other grant applications and/or other funded projects.
• The required disclosure will not affect a grant’s scientific review or consideration. As TAAF does not provide overlapping funds, receipt of an overlapping grant award will impact the level of funding awarded. However, TAAF will provide the maximum benefit possible. Failure to disclose the required information in a timely manner will result in an administrative disqualification of an application or the withdrawal of a grant award.

Application Requirements

• Social Media Requirements:
  • In conjunction with the reporting requirements, grant recipients are expected to include The Aneurysm and AVM Foundation (TAAF) when referencing their project on social media platforms. TAAF utilizes Facebook, Twitter and Instagram, but would expect to be included in any platform when grantee references the granted project.

For more information, visit TAAF.